Form D Explorer
Cantai Therapeutics, Inc. · CIK 1991732

Report a data issueCitable research briefCompare issuerPrivate research collection

Cantai Therapeutics, Inc.

CIK 1991732 · Corporation · Inc. DELAWARE · PHILADELPIA, Pennsylvania · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Jul 15, 2025
through Jan 21, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJul 15, 2025 · DJan 21, 2026 · DLater minus earlier
Reported offering amount$1,100,000$3,000,000$1,900,000
Reported amount sold$550,000$3,000,000$2,450,000
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001991732-25-000002 · Later SEC source: 0001991732-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Jan 21, 2026

Reported offering amount
$3,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$3,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)